PI Industries has reported robust financial results for Q2 FY25, showing solid growth in profitability and an improvement in operating margins. The agrochemical company’s net profit rose by 5.8% year-on-year (YoY), and EBITDA margins expanded, reflecting effective cost management and operational efficiency.
Key Financial Highlights for Q2 FY25:
- Revenue from Operations: ₹2,221 crore, a 4.9% increase from ₹2,116.9 crore in the same quarter last year.
- Net Profit: ₹508.2 crore, up 5.8% YoY from ₹480.5 crore in Q2 FY24.
- EBITDA: ₹628.2 crore, marking a 13.9% YoY growth from ₹551.4 crore in the previous year.
- EBITDA Margin: Expanded to 28.3%, up from 26.1% in Q2 FY24, indicating enhanced profitability.
Strategic Developments
In June 2024, PI Industries announced its board’s approval for the acquisition of UK-based Plant Health Care Plc (PHC) for approximately £32.8 million. This acquisition aligns with the company’s strategy to strengthen its product portfolio in plant health solutions and broaden its global presence.
Summary
PI Industries’ strong Q2 performance, driven by revenue growth and margin expansion, reflects the company’s resilience and focus on profitability. The recent acquisition of Plant Health Care Plc further positions PI Industries for future growth in the agrochemical sector. With steady financial performance and strategic moves, PI Industries remains a stock to watch for investors looking at growth in the agricultural input market.
